Although the present study provided a noval lncRNA-- RP11-59J16.2 probably related to the development of AD by affecting cell apoptosis and Tau phosphorylation through regulation of MCM2, it still had some limitations. The gene discussed is MAPT; the disease is Alzheimer disease.